Cohance Lifesciences schedules conference call on May 12, 2026 to discuss Q4 & FY26 audited financial results.
Senior management will present results followed by Q&A session with investors and analysts.
Company confirms no unpublished price sensitive information will be shared during the call.
Dial-in numbers provided for global access with pre-registration option available for participants.